ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
21.270,37
0,05%
S&P 500
6.086,37
0,61%
Dow Jones
44.156,73
0,30%
Euro vs US Dollar
1,04032
-0,05%
Bitcoin
102.224,46
-1,36%
Pepperstone
Advertisement
Registration Strip Icon for default Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Inhibrx Biosciences Inc (INBX)

  7. Inhibrx Biosciences Inc (INBX) News

INBX

Inhibrx Biosciences (INBX)

Inhibrx Biosciences Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:INBX
DatumZeitQuelleÜberschriftSymbolFirma
21/01/202523h01PR Newswire (US)Inhibrx Biosciences Announces Preliminary Data from the Phase 1 Trial of ozekibart (INBRX-109) for the Treatment of Colorectal CancerNASDAQ:INBXInhibrx Biosciences Inc
13/01/202522h15PR Newswire (US)Inhibrx Biosciences Announces Loan Agreement with Oxford FinanceNASDAQ:INBXInhibrx Biosciences Inc
14/11/202422h24PR Newswire (US)Inhibrx Biosciences Reports Third Quarter 2024 Financial ResultsNASDAQ:INBXInhibrx Biosciences Inc
04/11/202422h00PR Newswire (US)Inhibrx Prevails in Trade Secret Case, Reaffirming Its Commitment to Integrity and InnovationNASDAQ:INBXInhibrx Biosciences Inc
14/08/202400h54PR Newswire (US)Inhibrx Biosciences Reports Second Quarter 2024 Financial Results and Recent Corporate HighlightsNASDAQ:INBXInhibrx Biosciences Inc
31/05/202422h30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INBXInhibrx Biosciences Inc
31/05/202400h21Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INBXInhibrx Biosciences Inc
30/05/202422h34Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:INBXInhibrx Biosciences Inc
30/05/202422h34Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:INBXInhibrx Biosciences Inc
30/05/202422h33Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:INBXInhibrx Biosciences Inc
30/05/202422h33Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:INBXInhibrx Biosciences Inc
30/05/202422h32Edgar (US Regulatory)Form POSASR - Post-effective Amendment to an automatic shelf registration statementNASDAQ:INBXInhibrx Biosciences Inc
30/05/202422h13Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:INBXInhibrx Biosciences Inc
28/05/202422h55Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:INBXInhibrx Biosciences Inc
25/05/202400h15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INBXInhibrx Biosciences Inc
24/05/202422h44Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:INBXInhibrx Biosciences Inc
24/05/202422h08Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:INBXInhibrx Biosciences Inc
24/05/202422h00PR Newswire (US)Inhibrx Inc. Stockholders Approve Sale of INBRX-101 to SanofiNASDAQ:INBXInhibrx Biosciences Inc
22/05/202415h54Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:INBXInhibrx Biosciences Inc
21/05/202403h48Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:INBXInhibrx Biosciences Inc
17/05/202423h29Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:INBXInhibrx Biosciences Inc
17/05/202422h25Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:INBXInhibrx Biosciences Inc
11/05/202400h36PR Newswire (US)Inhibrx, Inc. Announces Updated When-Issued Trading Date for Anticipated Spin-OffNASDAQ:INBXInhibrx Biosciences Inc
09/05/202422h08Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:INBXInhibrx Biosciences Inc
08/05/202422h57Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INBXInhibrx Biosciences Inc
08/05/202422h42Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:INBXInhibrx Biosciences Inc
08/05/202422h37PR Newswire (US)Inhibrx, Inc. Announces Record Date and Expected Distribution Time for Anticipated Spin-Off and the Expected Merger Effective Time for Anticipated MergerNASDAQ:INBXInhibrx Biosciences Inc
06/05/202423h16Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:INBXInhibrx Biosciences Inc
11/03/202421h26Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:INBXInhibrx Biosciences Inc
08/03/202422h08Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:INBXInhibrx Biosciences Inc
 Showing the most relevant articles for your search:NASDAQ:INBX

Kürzlich von Ihnen besucht

LSE
CRC
Circle Property
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2025 ADVFN PLC - Alle Rechte vorbehalten